Edition:
United States

Applied DNA Sciences Inc (APDN.OQ)

APDN.OQ on NASDAQ Stock Exchange Capital Market

1.42USD
3:59pm EST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.42
Open
$1.42
Day's High
$1.43
Day's Low
$1.42
Volume
925
Avg. Vol
26,784
52-wk High
$3.45
52-wk Low
$0.90

Latest Key Developments (Source: Significant Developments)

Applied DNA Reports Q1 Loss Per Share $0.12
Thursday, 8 Feb 2018 04:05pm EST 

Feb 8 (Reuters) - Applied Dna Sciences Inc ::APPLIED DNA REPORTS FISCAL FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.12.Q1 REVENUE FELL 28 PERCENT TO $648,000.SEES FY 2018 REVENUE $6.5 MILLION.  Full Article

Double Medical Technology unit obtains high-tech enterprise recognition
Wednesday, 7 Feb 2018 10:56pm EST 

Feb 8(Reuters) - Double Medical Technology Inc <002901.SZ> ::Says its unit recognized as high-tech enterprise .Says its unit will enjoy tax preference of 15 percent for three years from Dec. 1, 2017 .  Full Article

Applied DNA Sciences Establishes New Central DNA Testing Laboratory In India
Tuesday, 23 Jan 2018 05:30am EST 

Jan 23 (Reuters) - Applied Dna Sciences Inc ::APPLIED DNA SCIENCES INC SAYS HAS ESTABLISHED A CENTRAL DNA TESTING LABORATORY IN AHMEDABAD, INDIA, PROVIDING FULL FORENSIC AUTHENTICATION SERVICES.  Full Article

Wuhan Thalys Medical Technology and partner jointly sign contract with Pingdu People's Hospital
Monday, 8 Jan 2018 01:07am EST 

Jan 8(Reuters) - Wuhan Thalys Medical Technology Inc <603716.SS>:Says it and China Resources Shandong Pharmaceutical Co Ltd jointly signed contract with Pingdu People's Hospital, regarding centralized purchasing and supply of test reagent and consumable.  Full Article

Wuhan Thalys Medical Technology signs contracts with Wuhan Hospital of Traditional Chinese Medicine
Monday, 8 Jan 2018 12:59am EST 

Jan 8(Reuters) - Wuhan Thalys Medical Technology Inc <603716.SS>:Says it signed contracts with Wuhan Hospital of Traditional Chinese Medicine, regarding centralized delivery of test reagent and consumable.  Full Article

Applied DNA Sciences Q4 Revenue $1.1 Million
Thursday, 28 Dec 2017 04:05pm EST 

Dec 28 (Reuters) - Applied Dna Sciences Inc ::APPLIED DNA SCIENCES REPORTS YEAR END AND FISCAL FOURTH QUARTER RESULTS.Q4 LOSS PER SHARE $0.10.Q4 REVENUE FELL 30 PERCENT TO $1.1 MILLION.  Full Article

Wuhan Thalys Medical Technology unit sets up medical tech unit in Tai'an City
Tuesday, 19 Dec 2017 04:51am EST 

Dec 19(Reuters) - Wuhan Thalys Medical Technology Inc <603716.SS>:Says co's Jinan-based medical technology unit sets up a wholly owned medical technology unit in Tai'an City, with registered capital of 10 million yuan .  Full Article

Applied DNA And Colorcon To Collaborate To Commercialize Product Authentication Technology
Monday, 18 Dec 2017 05:30am EST 

Dec 18 (Reuters) - Applied Dna Sciences Inc ::APPLIED DNA AND COLORCON ANNOUNCE COLLABORATION TO COMMERCIALIZE PRODUCT AUTHENTICATION TECHNOLOGY FOR PHARMACEUTICAL AND NUTRACEUTICAL INDUSTRY.APPLIED DNA SCIENCES INC - CO, COLORCON INC HAVE ENTERED INTO A TECHNOLOGY LICENSE MEMORANDUM OF UNDERSTANDING.APPLIED DNA SCIENCES - DEAL TO COMMERCIALIZE PLATFORM FOR TRACEABILITY DIRECTLY ON DOSE, IS INTENDED TO REDUCE RISKS ASSOCIATED WITH COUNTERFEIT MEDICATIONS.  Full Article

Applied DNA Q4 Loss Per Share $0.10
Friday, 15 Dec 2017 05:23pm EST 

Dec 15 (Reuters) - Applied DNA Sciences Inc ::APPLIED DNA ANNOUNCES SELECTED PRELIMINARY UNAUDITED FISCAL FOURTH QUARTER AND YEAR END RESULTS.Q4 LOSS PER SHARE $0.10.Q4 REVENUE FELL 30 PERCENT TO $1.1 MILLION.  Full Article

APPLIED DNA SECURES 1-YEAR CONTRACT EXTENSION WITH DEFENSE LOGISTICS AGENCY
Monday, 20 Nov 2017 05:30am EST 

Nov 20 (Reuters) - Applied DNA Sciences Inc ::APPLIED DNA SCIENCES INC - ‍DEFENSE LOGISTICS AGENCY (DLA) HAS AWARDED CO A ONE-YEAR EXTENSION OF ITS CURRENT CONTRACT THROUGH OCTOBER 13, 2018​.  Full Article

BRIEF-Applied DNA Reports Q1 Loss Per Share $0.12

* APPLIED DNA REPORTS FISCAL FIRST QUARTER 2018 FINANCIAL RESULTS